Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
4
×
national blog main
4
×
boston blog main
boston top stories
clinical trials
cancer
cancer drugs
deals
fda
national top stories
roche
san francisco blog main
alexion pharmaceuticals
alnylam pharmaceuticals
amgen
artificial intelligence
black diamond therapeutics
bladder cancer
blueprint medicines
boehringer ingelheim
boston
cobimetinib
deciphera pharmaceuticals
dicerna pharamceuticals
eli lilly
endometral cancer
europe blog main
european society for medical oncology
glioblastoma
hepatitis b
hepatitis b virus
hereditary transthyretin amyloidosis
investing
ipo
loxo oncology
mirati therapeutics
national
new enterprise associates
patisiran
What
drug
4
×
research
4
×
medicines
cancer
ipo
targets
alex
announced
biotech
black
caught
causing
ceo
clinic
collaboration
companies
despite
diamond
dicerna
discovery
disease
eluded
entered
eye
family
gene
hardest
hepatitis
hit
hopes
hottest
hunters
insilico
intended
lead
leading
lines
medicine
molecular
nears
Language
unset
4
×
Current search:
drug
×
biotech
×
unset
×
" life sciences "
×
" national blog main "
×
research
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug